Literature DB >> 12676992

C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs.

Madeleine Grooteclaes1, Quinn Deveraux, Jeffrey Hildebrand, Qinghong Zhang, Richard H Goodman, Steven M Frisch.   

Abstract

The genesis of carcinoma cells often involves epithelial-to-mesenchymal transitions and the acquisition of apoptosis resistance, but it is unclear whether these alterations are controlled coordinately or independently. Our previously reported effects of adenovirus E1a in human tumor cells raised the possibility that the E1a-interacting corepressor protein C-terminal-binding protein (CtBP) might selectively repress epithelial cell adhesion and proapoptotic genes. Here, we report that CtBP-knockout cells were hypersensitive to apoptosis. Correspondingly, microarray analysis of CtBP-knockout vs. CtBP-rescued mouse embryo fibroblasts revealed that many epithelial-specific and proapoptotic genes were indeed regulated by CtBP. Neither the apoptosis nor the repression activities of CtBP required histidine-315, suggesting that the proposed dehydrogenase activity is not essential for CtBP function. The results presented herein establish two functional roles of CtBP: to corepress epithelial genes, thus permitting epithelial-to-mesenchymal transitions, and to modulate the cellular threshold for apoptotic responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676992      PMCID: PMC153596          DOI: 10.1073/pnas.0830998100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Evidence for a function of CtBP in epithelial gene regulation and anoikis.

Authors:  M L Grooteclaes; S M Frisch
Journal:  Oncogene       Date:  2000-08-03       Impact factor: 9.867

2.  Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation, and apoptosis.

Authors:  S Parrinello; C Q Lin; K Murata; Y Itahana; J Singh; A Krtolica; J Campisi; P Y Desprez
Journal:  J Biol Chem       Date:  2001-08-09       Impact factor: 5.157

3.  The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion.

Authors:  J Comijn; G Berx; P Vermassen; K Verschueren; L van Grunsven; E Bruyneel; M Mareel; D Huylebroeck; F van Roy
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

4.  PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family.

Authors:  L D Attardi; E E Reczek; C Cosmas; E G Demicco; M E McCurrach; S W Lowe; T Jacks
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

Review 5.  The IGF axis and programmed cell death.

Authors:  A J Butt; S M Firth; R C Baxter
Journal:  Immunol Cell Biol       Date:  1999-06       Impact factor: 5.126

6.  Hypersensitivity to DNA damage leads to increased apoptosis during early mouse development.

Authors:  B S Heyer; A MacAuley; O Behrendtsen; Z Werb
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

7.  Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells.

Authors:  C M Perks; P V Newcomb; M R Norman; J M Holly
Journal:  J Mol Endocrinol       Date:  1999-04       Impact factor: 5.098

8.  Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells.

Authors:  N Sueoka; H Y Lee; S Wiehle; R J Cristiano; B Fang; L Ji; J A Roth; W K Hong; P Cohen; J M Kurie
Journal:  Oncogene       Date:  2000-09-07       Impact factor: 9.867

Review 9.  CtBP, an unconventional transcriptional corepressor in development and oncogenesis.

Authors:  G Chinnadurai
Journal:  Mol Cell       Date:  2002-02       Impact factor: 17.970

10.  FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts.

Authors:  A A Kuang; G E Diehl; J Zhang; A Winoto
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

View more
  92 in total

1.  CtBP contributes quantitatively to Knirps repression activity in an NAD binding-dependent manner.

Authors:  Montserrat Sutrias-Grau; David N Arnosti
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 2.  Snail family regulation and epithelial mesenchymal transitions in breast cancer progression.

Authors:  Antonio Garcia de Herreros; Sandra Peiró; Mayssaa Nassour; Pierre Savagner
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-09       Impact factor: 2.673

3.  The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1.

Authors:  Aurore Keutgens; Kateryna Shostak; Pierre Close; Xin Zhang; Benoît Hennuy; Marie Aussems; Jean-Paul Chapelle; Patrick Viatour; André Gothot; Marianne Fillet; Alain Chariot
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

4.  Conserved catalytic and C-terminal regulatory domains of the C-terminal binding protein corepressor fine-tune the transcriptional response in development.

Authors:  Yang W Zhang; David N Arnosti
Journal:  Mol Cell Biol       Date:  2010-11-15       Impact factor: 4.272

5.  CtBP1 interacts with Ikaros and modulates pituitary tumor cell survival and response to hypoxia.

Authors:  Katie Dorman; Zhongyi Shen; Caimei Yang; Shereen Ezzat; Sylvia L Asa
Journal:  Mol Endocrinol       Date:  2012-02-02

6.  Role of the C-terminal binding protein PXDLS motif binding cleft in protein interactions and transcriptional repression.

Authors:  Kate G R Quinlan; Alexis Verger; Alister Kwok; Stella H Y Lee; José Perdomo; Marco Nardini; Martino Bolognesi; Merlin Crossley
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

7.  Role of transcriptional corepressor CtBP1 in prostate cancer progression.

Authors:  Rui Wang; Irfan A Asangani; Balabhadrapatruni V S K Chakravarthi; Bushra Ateeq; Robert J Lonigro; Qi Cao; Ram-Shankar Mani; Daniel F Camacho; Natalie McGregor; Taibriana E W Schumann; Xiaojun Jing; Radhika Menawat; Scott A Tomlins; Heng Zheng; Arie P Otte; Rohit Mehra; Javed Siddiqui; Saravana M Dhanasekaran; Mukesh K Nyati; Kenneth J Pienta; Nallasivam Palanisamy; Lakshmi P Kunju; Mark A Rubin; Arul M Chinnaiyan; Sooryanarayana Varambally
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

8.  C-Terminal Binding Protein is Involved in Promoting to the Carcinogenesis of Human Glioma.

Authors:  Bo Liu; Gloria Di
Journal:  Mol Neurobiol       Date:  2016-10-03       Impact factor: 5.590

9.  Inhibition of C-terminal binding protein attenuates transcription factor 4 signaling to selectively target colon cancer stem cells.

Authors:  Jagrut Patel; Somesh Baranwal; Ian M Love; Nirmita J Patel; Steven R Grossman; Bhaumik B Patel
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.

Authors:  Min Li; Suzette Riddle; Hui Zhang; Angelo D'Alessandro; Amanda Flockton; Natalie J Serkova; Kirk C Hansen; Radu Moldovan; B Alexandre McKeon; Maria Frid; Sushil Kumar; Hong Li; Hongbing Liu; Angela Caánovas; Juan F Medrano; Milton G Thomas; Dijana Iloska; Lydie Plecitá-Hlavatá; Petr Ježek; Soni Pullamsetti; Mehdi A Fini; Karim C El Kasmi; QingHong Zhang; Kurt R Stenmark
Journal:  Circulation       Date:  2016-08-25       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.